Free to view
Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study
-
Author
-
Cite
BMJ Open 2020;10:e038102. doi: 10.1136/bmjopen-2020-038102
Free to view
Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?
-
Author
-
Cite
BMJ Evidence-Based Medicine Published Online First: 21 October 2020. doi: 10.1136/bmjebm-2020-111507
Free to view
Incidence of major and clinically relevant non-major bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular atrial fibrillation in secondary care: Results from the Rivaroxaban Observational Safety Evaluation (ROSE) study
-
Author
-
Cite
PLoS ONE October 2020 15(10): e0240489. https://doi.org/10.1371/journal.pone.0240489
Free to view
Observational assessment of safety in seroquel (OASIS): a specialist cohort event monitoring (SCEM) study in England
-
Author
-
Cite
Therapeutic Advances in Psychopharmacology. January 2020. https://doi.org/10.1177/2045125320954616
Free to view
Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment
-
Author
-
Cite
Drug Safety. 2020. https://doi.org/10.1007/s40264-020-00966-9
Free to view
Remdesivir in Treatment of COVID‑19: A Systematic Benefit–Risk Assessment
-
Author
-
Cite
Drug Safety. 2020. https://doi.org/10.1007/s40264-020-00952-1
Free to view
The UK BIO-TRAC Study: A Cross-Sectional Study of Product and Batch Traceability for Biologics in Clinical Practice and Electronic Adverse Drug Reaction Reporting in the UK
-
Author
-
Cite
Drug Safety. 2020 March, 43, 255–263 https://doi.org/10.1007/s40264-019-00891-6
Free to view
Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice
-
Author
-
Cite
Expert Opinion on Drug Safety 2020, DOI: 10.1080/14740338.2020.1798928
Free to view
Systematic benefit-risk assessment for buprenorphine implant: a semiquantitative method to support risk management
-
Author
-
Cite
BMJ Evidence-Based Medicine Published Online First: 24 February 2020. doi: 10.1136/bmjebm-2019-111295
First Conference on Big Data for Pharmacovigilance
-
Author
-
Cite
Drug Saf. 2018 Dec;41(12):1281-1284. doi: 10.1007/s40264-018-0727-2
Safety of Atrovent® CFC-free inhaler: respiratory events reported from an observational cohort study in England.
-
Author
-
Cite
Int J Pharm Pract. 2018 Aug;26(4):356-363
Utilisation and Safety of Deferasirox: Results from an Observational Cohort Study in England.
-
Author
-
Cite
Drug Safety 2018 Mar;41(3):267-275.
Free to view
Investigation assessing the publicly available evidence supporting postmarketing withdrawals, revocations and suspensions of marketing authorisations in the EU since 2012.
-
Author
-
Cite
BMJ Open 2018;8:e019759. doi: 10.1136/bmjopen-2017-019759
The 9th Biennial Conference on Signal Detection and Interpretation in Pharmacovigilance.
-
Author
-
Cite
Drug Saf. 2018 Jan;41(1):139-141
Drugs and life-threatening ventricular arrhythmia risk: results from the DARE study cohort.
-
Author
-
Cite
BMJ Open. 2017 Oct 16;7(10):e016627.
Evidence for the hERG Liability of Antihistamines, Antipsychotics, and Anti-Infective Agents: A Systematic Literature Review From the ARITMO Project.
-
Author
-
Cite
J Clin Pharmacol. 2017 May;57(5):558-572
Use of atomoxetine and suicidal ideation in children and adolescents: Results of an observational cohort study within general practice in England.
-
Author
-
Cite
Eur Psychiatry. 2017 Jan;39:11-16.
Utilisation and Tolerability of Aliskiren in the Primary Care Setting in England.
-
Author
-
Cite
J Clin Hypertens (Greenwich). 2016 Dec;18(12):1237-1243
Pattern of Onset and Risk Factors for Peripheral Oedema During Vildagliptin Use: Analysis from the Vildagliptin Prescription-Event Monitoring Study in England.
-
Author
-
Cite
Drug Safety 2016 Nov;39(11):1093-1104.
Free to view
Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England
-
Author
-
Cite
Drug Safety. April 2016, Volume 39, Issue 4, pp 323–333
Free to view
Vulnerable Patients and Potential Harms: The Contribution of Observational Research.
-
Author
-
Cite
Drug Safety. April 2016, Volume 39, Issue 4, pp 277–280.
Utilisation of extended release quetiapine (Seroquel XL™): Results from an observational cohort study in England.
-
Author
-
Cite
Eur Psychiatry. 2016 Mar;33:61-7
Sudden cardiac and sudden unexpected death related to antipsychotics: A meta-analysis of observational studies
-
Author
-
Cite
Clin Pharmacol Ther. 2016 Mar;99(3):306-14
Contribution of UK Prescription-Based Event Monitoring Methods in the Pharmacovigilance of Psychotropic Medications
-
Author
-
Cite
Chapter in "Pharmacovigilance in Psychiatry", 2016, edited by Edoardo Spina and Gianluca Trifirò, published by ADIS
Free to view
The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.
-
Author
-
Cite
Drug Safety 2016 Jan Volume39(1):59–68
